• DOI:10.1080/13697130500330309
Corpus ID: 31883491

Added benefits of drospirenone for compliance

@article{Foidart2005AddedBO,
  title={Added benefits of drospirenone for compliance},
  author={J. Foidart},
  journal={Climacteric},
  year={2005},
  volume={8},
  pages={28 - 34}
}

• J. Foidart
• Published 2005
• Medicine
• Climacteric

Drospirenone is a novel progestogen that possesses antimineralocorticoid activity. This activity is seen clinically in its effects on physiological parameters, body weight, general well-being and fluid-related symptoms. Clinical studies with an oral contraceptive containing 30 μg ethinylestradiol and 3 mg drospirenone (Yasmin®, Schering AG, Berlin, Germany) and a new continuous combined oral hormone replacement therapy (HRT) containing 1 mg 17β-estradiol and 2 mg drospirenone (Angeliq… Expand